首页> 外文期刊>Clinical oncology >A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer.
【24h】

A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer.

机译:局部切除和腋窝淋巴结清扫术后早期乳腺癌的全乳与肿瘤床照射的随机研究。

获取原文
获取原文并翻译 | 示例
       

摘要

AIMS: Whole-breast radiotherapy (WBRT) after conservative surgery for early breast cancer is a routine standard of care. Despite this, a number of uncertainties in management still exist. Over recent years, a number of new technologies have allowed the development of partial-breast irradiation, with the intention of improving the risk-benefit relationship of routine breast radiotherapy. We report the results of a trial comparing partial- with WBRT, with prolonged follow-up. MATERIALS AND METHODS: Between 1986 and 1990, 174 women were randomised to receive conventional whole-breast radiotherapy (WBRT) (40 Gy in 15 fractions), with a tumour-bed boost or partial-breast irradiation by a variety of techniques. Recruitment was problematic, and the trial closed prematurely well before meeting its recruitment target. RESULTS: A trend was observed towards higher local recurrence and a higher locoregional recurrence rate after irradiation of the tumour bed alone. Distant recurrence and survival were the same. CONCLUSIONS: Conclusions are limited in view of the failure to complete accrual of the target of 400 participants, and in the context of the techniques of partial-breast radiotherapy used during this study, which would not compare with those in current use. Tumour-bed irradiation alone cannot currently be recommended as routine treatment outside the context of clinical trial.
机译:目的:保守治疗早期乳腺癌的全乳放疗(WBRT)是常规的护理标准。尽管如此,管理中仍存在许多不确定性。近年来,许多新技术允许部分乳房放疗的发展,目的是改善常规乳房放疗的风险-收益关系。我们报告了将WBRT与部分WBRT进行比较的试验结果,并进行了长期随访。材料与方法:在1986年至1990年之间,随机分配了174例妇女接受常规全乳放疗(WBRT)(15馏分中的40 Gy),并通过多种技术增强了肿瘤床或部分乳腺照射。招聘存在问题,并且审判在达成其招聘目标之前就提前结束。结果:观察到单独照射肿瘤床后局部复发率和局部复发率较高的趋势。远处复发和生存是相同的。结论:鉴于未能完成对400名参与者的目标的应计,并且在此研究期间使用的部分乳房放疗技术的背景下,结论与目前使用的那些相比尚有限。目前,在临床试验范围之外,目前尚不建议单独使用肿瘤床照射作为常规治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号